As the “peptide craze” fuels a surge in unregulated vendors, pharmacists must serve as critical navigators to steer patients toward safe, pharmaceutical-grade alternatives.
Christopher Shade, PhD
Advertisement
Christopher Shade, PhD, CEO and founder of Quicksilver Scientific
Articles by Christopher Shade, PhD
Following an FDA announcement on its deeper look into peptide restrictions, Christopher Shade, PhD, joined to provide insights on their functions for metabolic health and more.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Some Providers Prescribe Unapproved Retatrutide for Weight Loss at Alarming Rate
2
A Practical Guide for Pharmacy Drug Shortages
3
Payer Preference Shifts Toward Unbundled, Transparent PBM Models
4
The Role of the Pharmacist in Health Disparities in Cardiometabolic Disease
5